Bulletin
Investor Alert

London Markets Open in:

July 17, 2020, 5:09 a.m. EDT

RNA-Based Therapeutics and Vaccines Market 2020 Global Overview, Latest Technologies, Business Strategy, Key Vendors, Segments, Demands, Growth Factors, Size, Share by Forecast to 2026

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jul 17, 2020 (Profound via COMTEX) -- A recent report provides crucial insights along with application based and forecast information in the Global RNA-Based Therapeutics and Vaccines Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the RNA-Based Therapeutics and Vaccines market.

With increasing cases of obesity all over the globe, a need for conducting an in-depth study about this healthcare issue led to the development of this report. Increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress, are key market drivers. The report discusses more information about these subjects, with a focus on the rising need for RNA-Based Therapeutics and Vaccines.

Download Sample - https://www.qyresearchmedical.com/sample/70032

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period. With healthcare being a sensitive topic, a separate analysis is included that discusses the widespread continuing obesity all over the globe consequently increasing demand for surgical devices.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified.

Key Players of the global RNA-Based Therapeutics and Vaccines market are included as given below:

Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis
RNA-Based Therapeutics and Vaccines Breakdown Data by Type
RNA-Based Therapeutics
RNA-Based Vaccines
RNA-Based Therapeutics and Vaccines Breakdown Data by Application
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others

Download Full Report - https://www.qyresearchmedical.com/report/checkout/70032/3500

Reasons to Purchase This Report:

  • Estimates RNA-Based Therapeutics and Vaccines development trends with SWOT analysis

  • Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players

  • Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion

  • Market dynamics and opportunities for growth for players in the near future

  • Competitive landscape describing the RNA-Based Therapeutics and Vaccines market revenue shares of key players.

  • Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects

TABLE OF CONTENT

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue
1.4 Market by Type
1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 RNA-Based Therapeutics
1.4.3 RNA-Based Vaccines
1.5 Market by Application
1.5.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Immunology
1.5.4 Ophthalmology
1.5.5 Cardiovascular Diseases
1.5.6 Infectious Diseases
1.5.7 Genetic Diseases
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global RNA-Based Therapeutics and Vaccines Market Perspective (2015-2026)
2.2 Global RNA-Based Therapeutics and Vaccines Growth Trends by Regions
2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 RNA-Based Therapeutics and Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 RNA-Based Therapeutics and Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 RNA-Based Therapeutics and Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key RNA-Based Therapeutics and Vaccines Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top RNA-Based Therapeutics and Vaccines Players by Market Size
3.1.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue (2015-2020)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global RNA-Based Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio
3.2.1 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by RNA-Based Therapeutics and Vaccines Revenue in 2019
3.3 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
3.4 Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
3.5 Date of Enter into RNA-Based Therapeutics and Vaccines Market
3.6 Mergers amp; Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Type (2015-2020)
4.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
5.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
6.2 RNA-Based Therapeutics and Vaccines Key Players in North America (2019-2020)
6.3 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
6.4 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)

7 Europe
7.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
7.2 RNA-Based Therapeutics and Vaccines Key Players in Europe (2019-2020)
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
7.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)

8 China
8.1 China RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
8.2 RNA-Based Therapeutics and Vaccines Key Players in China (2019-2020)
8.3 China RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
8.4 China RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)

9 Japan
9.1 Japan RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
9.2 RNA-Based Therapeutics and Vaccines Key Players in Japan (2019-2020)
9.3 Japan RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
9.4 Japan RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
10.2 RNA-Based Therapeutics and Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)

11 India
11.1 India RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
11.2 RNA-Based Therapeutics and Vaccines Key Players in India (2019-2020)
11.3 India RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
11.4 India RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)

12 Central amp; South America
12.1 Central amp; South America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
12.2 RNA-Based Therapeutics and Vaccines Key Players in Central amp; South America (2019-2020)
12.3 Central amp; South America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
12.4 Central amp; South America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Alnylam Pharmaceuticals
13.1.1 Alnylam Pharmaceuticals Company Details
13.1.2 Alnylam Pharmaceuticals Business Overview
13.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020))
13.1.5 Alnylam Pharmaceuticals Recent Development
13.2 Arbutus Biopharma
13.2.1 Arbutus Biopharma Company Details
13.2.2 Arbutus Biopharma Business Overview
13.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Introduction
13.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.2.5 Arbutus Biopharma Recent Development
13.3 Arrowhead Pharmaceuticals
13.3.1 Arrowhead Pharmaceuticals Company Details
13.3.2 Arrowhead Pharmaceuticals Business Overview
13.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.3.5 Arrowhead Pharmaceuticals Recent Development
13.4 BioNTech
13.4.1 BioNTech Company Details
13.4.2 BioNTech Business Overview
13.4.3 BioNTech RNA-Based Therapeutics and Vaccines Introduction
13.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.4.5 BioNTech Recent Development
13.5 CureVac
13.5.1 CureVac Company Details
13.5.2 CureVac Business Overview
13.5.3 CureVac RNA-Based Therapeutics and Vaccines Introduction
13.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.5.5 CureVac Recent Development
13.6 Dicerna Pharmaceuticals
13.6.1 Dicerna Pharmaceuticals Company Details
13.6.2 Dicerna Pharmaceuticals Business Overview
13.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.6.5 Dicerna Pharmaceuticals Recent Development
13.7 Regulus Therapeutics
13.7.1 Regulus Therapeutics Company Details
13.7.2 Regulus Therapeutics Business Overview
13.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.7.5 Regulus Therapeutics Recent Development
13.8 Marina Biotech
13.8.1 Marina Biotech Company Details
13.8.2 Marina Biotech Business Overview
13.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Introduction
13.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.8.5 Marina Biotech Recent Development
13.9 MiRagen Therapeutics
13.9.1 MiRagen Therapeutics Company Details
13.9.2 MiRagen Therapeutics Business Overview
13.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.9.5 MiRagen Therapeutics Recent Development
13.10 Moderna Therapeutics
13.10.1 Moderna Therapeutics Company Details
13.10.2 Moderna Therapeutics Business Overview
13.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.10.5 Moderna Therapeutics Recent Development
13.11 Quark Pharmaceuticals
10.11.1 Quark Pharmaceuticals Company Details
10.11.2 Quark Pharmaceuticals Business Overview
10.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
10.11.4 Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.11.5 Quark Pharmaceuticals Recent Development
13.12 Roche
10.12.1 Roche Company Details
10.12.2 Roche Business Overview
10.12.3 Roche RNA-Based Therapeutics and Vaccines Introduction
10.12.4 Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.12.5 Roche Recent Development
13.13 Sylentis
10.13.1 Sylentis Company Details
10.13.2 Sylentis Business Overview
10.13.3 Sylentis RNA-Based Therapeutics and Vaccines Introduction
10.13.4 Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.13.5 Sylentis Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

Download Full Report - https://www.qyresearchmedical.com/report/checkout/70032/3500

PDF File Dispatch Time - 24 Hours. We will also support Word, PPT, and Excel Files Dispatch

Contact Us:

QYResearch Medical

URL - http://www.qyresearchmedical.com/

Mailing Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Any Assistance, Email ndash; sales@qyresearchmedical.com

COMTEX_368153140/2630/2020-07-17T05:08:54

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.